Lucy Therapeutics
PrivateLast Round
Grant
May 28, 2024
Total Funding Raised
$25.94M
Company Overview
Lucy Therapeutics is a biotechnology company that develops proprietary mitochondrial-based small molecule therapies and diagnostic biomarkers for complex neurological diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lucy Therapeutics Comparables
Compare Lucy Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vincere Biosciences | 88% | |
| Mitochon Pharmaceuticals | 87% | |
| Acurex Biosciences | 87% | |
Lucy Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 28, 2024 | ||||
| VC Round | May 28, 2024 | ||||
| Grant | Oct 11, 2023 | ||||
| Grant | Apr 11, 2022 | ||||
| Series A | Jan 6, 2022 | ||||
Seed | Jun 28, 2019 |
Lucy Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Engine Ventures | Series A, Seed, Grant |
| Parkinson's UK | VC Round, Grant |
| International Rett Syndrome Foundation | Grant |
| Massachusetts Life Sciences Center | Series A |
| Safar Partners | Series A, VC Round, Seed, Grant |
| The Michael J. Fox Foundation for Parkinson's Research | VC Round, Grant |
| Engine Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
Monthly visitors increased 154% MoM, reaching 960.
- May 28, 2024
$2M round led by Engine Ventures and Safar Partners.
Lucy Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lucy Therapeutics's valuation, stock price, and market status.